Search research articles
Contact Us
Filters
Showing results (21-30 of 79) with videos related to
Page
of 8
Sort By:
Der Urologe. Ausg. A
|
September 18, 2010
[Targeted therapy of urological tumours. Experimental field or established therapeutic approach?]
M W Kramer, S Krege, I Peters, et al.
Aktuelle Urologie
|
June 21, 2017
[Intravesical salpingiosis: case report and review of the literature]
N Gilbert, X Guo, J Bauer, et al.
Der Urologe. Ausg. A
|
September 22, 2019
[Rate of thrombosis and bleeding after urological surgery under standardized anticoagulation]
S K Morische, M W Kramer, A S Merseburger, et al.
Urology
|
November 17, 2001
Use of serum creatinine to predict pathologic stage and recurrence among radical prostatectomy patients
A S Merseburger, R R Connelly, L Sun, et al.
Der Urologe. Ausg. A
|
October 20, 2011
[Systemic and surgical management of metastatic renal cell carcinoma]
M W Kramer, A S Merseburger, I Peters, et al.
Der Urologe. Ausg. A
|
January 11, 2020
S K Morische, M W Kramer, A S Merseburger, et al.
Aktuelle Urologie
|
January 26, 2018
[The impact of the androgen receptor splice variant AR-V7 on the prognosis and treatment of advanced prostate cancer]
P Thelen, H Taubert, S Duensing, et al.
Actas Urologicas Espanolas
|
September 20, 2012
[European Association of Urology guidelines on laser technologies]
T R W Herrmann, E N Liatsikos, U Nagele, et al.
Der Urologe. Ausg. A
|
August 2, 2008
[Expression of corticotropin releasing factor receptor 2 (CRFR2) in the human prostate. A new potential target for medical therapy of benign prostatic hyperplasia]
H Tezval, A S Merseburger, M Seidler, et al.
Der Urologe. Ausg. A
|
June 21, 2008
[Somatostatin analogs for the treatment of advanced, hormone-refractory prostate cancer: a possibility for secondary hormonal ablation?]
D Schilling, R Küfer, S Kruck, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 79) with videos related to
Sort By:
Page
of 8
Der Urologe. Ausg. A
|
September 18, 2010
[Targeted therapy of urological tumours. Experimental field or established therapeutic approach?]
M W Kramer, S Krege, I Peters, et al.
Aktuelle Urologie
|
June 21, 2017
[Intravesical salpingiosis: case report and review of the literature]
N Gilbert, X Guo, J Bauer, et al.
Der Urologe. Ausg. A
|
September 22, 2019
[Rate of thrombosis and bleeding after urological surgery under standardized anticoagulation]
S K Morische, M W Kramer, A S Merseburger, et al.
Urology
|
November 17, 2001
Use of serum creatinine to predict pathologic stage and recurrence among radical prostatectomy patients
A S Merseburger, R R Connelly, L Sun, et al.
Der Urologe. Ausg. A
|
October 20, 2011
[Systemic and surgical management of metastatic renal cell carcinoma]
M W Kramer, A S Merseburger, I Peters, et al.
Der Urologe. Ausg. A
|
January 11, 2020
S K Morische, M W Kramer, A S Merseburger, et al.
Aktuelle Urologie
|
January 26, 2018
[The impact of the androgen receptor splice variant AR-V7 on the prognosis and treatment of advanced prostate cancer]
P Thelen, H Taubert, S Duensing, et al.
Actas Urologicas Espanolas
|
September 20, 2012
[European Association of Urology guidelines on laser technologies]
T R W Herrmann, E N Liatsikos, U Nagele, et al.
Der Urologe. Ausg. A
|
August 2, 2008
[Expression of corticotropin releasing factor receptor 2 (CRFR2) in the human prostate. A new potential target for medical therapy of benign prostatic hyperplasia]
H Tezval, A S Merseburger, M Seidler, et al.
Der Urologe. Ausg. A
|
June 21, 2008
[Somatostatin analogs for the treatment of advanced, hormone-refractory prostate cancer: a possibility for secondary hormonal ablation?]
D Schilling, R Küfer, S Kruck, et al.
Page
of 8